the present invention relates to combinations of (n - [2 - (2,1,3 - benzothiadiazol - ylamino) - 6 - (2,6-dichlorophenyl) pyrido [2,3-d] pyrimidin - yl] - n '- (1,1-dimethylethyl) - urea and cytarabine and their use for the treatment of leukemia or the cma.
展开▼